Low vitamin D levels affect drug efficacy in HCV patients

12/20/2009 | Medscape (free registration)

An Italian study showed hepatitis C patients have lower serum levels of 25-hydroxyvitamin D than people without the virus, which affects treatment efficacy. The study showed that as vitamin D levels decline, so do the chances that a patient with chronic HCV will have a sustained response to interferon and ribavirin.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ